產品名稱 EML 425
產品貨號 Axon 2568 CAS [1675821-32-5] MF C27H24N2O4MW 440.49 Purity: 99% Soluble in DMSO Description Potent, selective and cell permeable reversible dual inhibitor of CBP and p300 (IC50 values 1.1 μM and 2.9 μM, respectively, and practically inactive against the enzymes GCN5 and PCAF), noncompetitive versus both acetyl-CoA and a histone H3 peptide. EML425 induced a marked and time-dependent reduction in the acetylation of lysine H4K5 and H3K9, a marked arrest in the G0/G1 phase and a significant increase in the hypodiploid nuclei percentage in human leukemia U937 cells. EML425's potency is comparable to that of C646 (Axon 1781). KEYWORDS:?EML 425 | supplier | dual CBP/p300 KAT3 inhibitor | EML425 | CAS [1675821-32-5] | Histone | HAT | Inhibitor | Lysine acyltransferase | H4K5 | H3K9 | G0/G1 arrest | hypodiploid nuclei | C646
產品價格 現(xiàn)貨詢價，電話：010-67529703
產品規(guī)格
產品品牌 axonmedchem
產品概述
產品詳情

EML 425

Based on 4 reference(s) in Google Scholar 8 10 4

Axon 2568

CAS [1675821-32-5]

MF C27H24N2O4
MW 440.49

  • Purity: 99%
  • Soluble in DMSO

EML 425

Description

Potent, selective and cell permeable reversible dual inhibitor of CBP and p300 (IC50 values 1.1 μM and 2.9 μM, respectively, and practically inactive against the enzymes GCN5 and PCAF), noncompetitive versus both acetyl-CoA and a histone H3 peptide. EML425 induced a marked and time-dependent reduction in the acetylation of lysine H4K5 and H3K9, a marked arrest in the G0/G1 phase and a significant increase in the hypodiploid nuclei percentage in human leukemia U937 cells. EML425's potency is comparable to that of C646 (Axon 1781).

KEYWORDS:?EML 425 | supplier | dual CBP/p300 KAT3 inhibitor | EML425 | CAS [1675821-32-5] | Histone | HAT | Inhibitor | Lysine acyltransferase | H4K5 | H3K9 | G0/G1 arrest | hypodiploid nuclei | C646
產品資料